(Q39800417)

English

Emergent biomarker derived from next-generation sequencing to identify pain patients requiring uncommonly high opioid doses

scientific article published on 3 May 2016

Statements

Emergent biomarker derived from next-generation sequencing to identify pain patients requiring uncommonly high opioid doses (English)
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit